NeuroVive’s Board Members and Senior Executives subscribe to shares in the ongoing rights issue
In the ongoing rights issue in NeuroVive, the Board and Senior Executives have undertaken to subscribe for at least 446,176 shares.
Press releases
NeuroVive provides an update on the impact of the COVID-19 pandemic on the company’s activities
NeuroVive (Nasdaq Stockholm: NVP) announces today that the overall work on the company’s study program is continuing and the company reports on the preparations being made to minimize delays in its va ...
NeuroVive clarifies strategy for NeuroSTAT
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) today announced that it intends to initiate a process with the aim to transfer the rights to develop and commercialize its NeuroSTAT program into a ...